← Back to Search

Other

Coffee for Type 2 Diabetes

Verified Trial
N/A
Recruiting
Led By Daniel Lamport, PhD
Research Sponsored by University of Reading
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are you between 30-70 years old?
Have you been formally diagnosed with Type II Diabetes for a year or more?
Must not have
You have been diagnosed with Type 1 Diabetes
You have been diagnosed with Gestational Diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up -4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial explores the effects of specialty coffee on cognitive function & blood sugar control in people with diabetes, to reduce risk of cognitive decline & diabetes.

Who is the study for?
This trial is for people aged 55-70 with Type 2 Diabetes who have been diagnosed for at least 3 years. They should currently drink coffee, but no more than 4 cups a day, and not be dependent on insulin or already drinking specialty coffee.
What is being tested?
The study tests if 'specialty coffee' high in chlorogenic acid (CGA) improves brain function and blood sugar control in Type 2 Diabetics compared to regular coffee. Participants will be split into two groups: one drinks specialty coffee, the other conventional, over an eight-week period after a four-week phase of only conventional coffee.
What are the potential side effects?
Since participants are current coffee drinkers, side effects may be minimal and similar to their usual experiences with caffeine. However, changes in cognitive function or blood sugar levels due to different types of coffees could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and -4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Verbal memory
Secondary study objectives
Anxiety symptoms
Depression symptoms
Executive Function
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CGA-rich coffee (Speciality coffee)Experimental Treatment1 Intervention
Participants will be provided with a single origin, CGA-rich specialty coffee as graded by the Specialty Coffee Association of America's Q-grading system to brew and consume
Group II: Conventional coffeeActive Control1 Intervention
Participants will be provided with a conventional, low CGA coffee to brew and consume which contains less CGA than the experimental arm.

Find a Location

Who is running the clinical trial?

University of ReadingLead Sponsor
155 Previous Clinical Trials
18,068 Total Patients Enrolled
Daniel Lamport, PhDPrincipal InvestigatorUniversity of Reading
2 Previous Clinical Trials
170 Total Patients Enrolled

Media Library

Specialty Coffee (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05709847 — N/A
Type 2 Diabetes Research Study Groups: Conventional coffee, CGA-rich coffee (Speciality coffee)
Type 2 Diabetes Clinical Trial 2023: Specialty Coffee Highlights & Side Effects. Trial Name: NCT05709847 — N/A
Specialty Coffee (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05709847 — N/A
~3 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top